Pediatric Bacterial Meningitis Surveillance in Niger: Increased Importance of Neisseria meningitidis Serogroup C, and a Decrease in Streptococcus pneumoniae Following 13-Valent Pneumococcal Conjugate Vaccine Introduction

被引:10
|
作者
Hama, Mamadou Kourna [1 ]
Khan, Dam [2 ]
Laouali, Boubou [1 ]
Okoi, Catherine [2 ]
Yam, Abdoulaye [3 ]
Haladou, Moussa [3 ]
Worwui, Archibald [2 ]
Ndow, Peter Sylvanus [2 ]
Obama, Ricardo Nse [3 ]
Mwenda, Jason M. [4 ]
Biey, Joseph [4 ]
Ntsama, Bernard [5 ]
Kwambana-Adams, Brenda A. [2 ]
Antonio, Martin [2 ,6 ]
Senghore, Madikay
Usuf, Effua
Uzochukwu, Egere
Zaman, Akram
Gehre, Florian
Tientcheu, Leopold
Mohammed, Nuredin Ibrahim
Dube, Felix
Ndow, Peter
Sambou, Suso
Jarju, Sheikh
Khan, Dam [2 ]
Chinelo, Ebruke
Bancroft, Rowan
机构
[1] Lab Hop Natl Niamey, Niamey, Niger
[2] London Sch Hyg & Trop Med, Med Res Council Unit Gambia, Collaborating Ctr New Vaccines Surveillance, WHO, London, England
[3] WHO Country Off, Niamey, Niger
[4] WHO Reg Off Africa, Brazzaville, Rep Congo
[5] WHO Intercountry Support Team West Africa, Ouagadougou, Burkina Faso
[6] Univ Warwick, Warwick Med Sch, Microbiol & Infect Unit, Coventry, W Midlands, England
关键词
meningitis; Niger; cerebrospinal fluid; N; meningitidis; S; pneumoniae; HAEMOPHILUS-INFLUENZAE; ANTIMICROBIAL RESISTANCE; MENINGOCOCCAL SEROGROUP; PHYLOGENETIC ANALYSIS; DISEASE; EPIDEMIC; OUTBREAK; NIAMEY; ASSAY; TOOL;
D O I
10.1093/cid/ciz598
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. Meningitis is endemic in Niger. Haemophilus influenzae type b (Hib) vaccine and the 13-valent pneumococcal conjugate vaccine (PCV13) were introduced in 2008 and 2014, respectively. Vaccination campaign against Neisseria meningitidis serogroup A was carried out in 2010-2011. We evaluated changes in pathogen distribution using data from hospital-based surveillance in Niger from 2010 through 2016. Methods. Cerebrospinal fluid (CSF) specimens from children <5 years old with suspected meningitis were tested to detect vaccine-preventable bacterial pathogens. Confirmatory identification and serotyping/grouping of Streptococcus pneumoniae, N. meningitidis, and H. influenzae were done. Antimicrobial susceptibility testing and whole genome sequencing were performed on S. pneumoniae isolates. Results. The surveillance included 2580 patients with suspected meningitis, of whom 80.8% (2085/2580) had CSF collected. Bacterial meningitis was confirmed in 273 patients: 48% (131/273) was N. meningitidis, 45% (123/273) S. pneumoniae, and 7% (19/273) H. influenzae. Streptococcus pneumoniae meningitis decreased from 34 in 2014, to 16 in 2016. PCV13 serotypes made up 88% (7/8) of S. pneumoniae meningitis prevaccination and 20% (5/20) postvaccination. Neisseria meningitidis serogroup C (NmC) was responsible for 59% (10/17) of serogrouped N. meningitidis meningitis. Hib caused 67% (2/3) of the H. influenzae meningitis isolates serotyped. Penicillin resistance was found in 16% (4/25) of S. pneumoniae isolates. Sequence type 217 was the most common lineage among S. pneumoniae isolates. Conclusions. Neisseria meningitidis and S. pneumoniae remain important causes of meningitis in children in Niger. The decline in the numbers of S. pneumoniae meningitis post-PCV13 is encouraging and should continue to be monitored. NmC is the predominant serogroup causing N. meningitidis meningitis.
引用
收藏
页码:S133 / S139
页数:7
相关论文
共 50 条
  • [11] A longitudinal study of streptococcus pneumoniae carriage in healthy children in the 13-valent pneumococcal conjugate vaccine era
    Mameli, Chiara
    Fabiano, Valentina
    Daprai, Laura
    Bedogni, Giorgio
    Faccini, Marino
    Garlaschi, Maria Laura
    Penagini, Francesca
    Dilillo, Dario
    Torresani, Erminio
    Gramegna, Maria
    Zuccotti, Gian Vincenzo
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2015, 11 (04) : 811 - 817
  • [12] Serotype distribution of invasive Streptococcus pneumoniae in Canada after the introduction of the 13-valent pneumococcal conjugate vaccine, 2010-2012
    Demczuk, Walter H. B.
    Martin, Irene
    Griffith, Averil
    Lefebvre, Brigitte
    McGeer, Allison
    Lovgren, Marguerite
    Tyrrell, Gregory J.
    Desai, Shalini
    Sherrard, Lindsey
    Adam, Heather
    Gilmour, Matthew
    Zhanel, George G.
    CANADIAN JOURNAL OF MICROBIOLOGY, 2013, 59 (12) : 778 - 788
  • [13] Increase of Macrolide-Resistance in Streptococcus pneumoniae Strains After the Introduction of the 13-Valent Pneumococcal Conjugate Vaccine in Lima, Peru
    Gonzales, Brayan E.
    Mercado, Erik H.
    Pinedo-Bardales, Maria
    Hinostroza, Noemi
    Campos, Francisco
    Chaparro, Eduardo
    Del Aguila, Olguita
    Castillo, Maria E.
    Saenz, Andres
    Reyes, Isabel
    Ochoa, Theresa J.
    FRONTIERS IN CELLULAR AND INFECTION MICROBIOLOGY, 2022, 12
  • [14] Trends in Asymptomatic Nasopharyngeal Colonization With Streptococcus pneumoniae After Introduction of the 13-valent Pneumococcal Conjugate Vaccine in Calgary, Canada
    Ricketson, Leah J.
    Wood, Melissa L.
    Vanderkooi, Otto G.
    MacDonald, Judy C.
    Martin, Irene E.
    Demczuk, Walter H. B.
    Kellner, James D.
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2014, 33 (07) : 724 - 730
  • [15] Bacterial Meningitis Due to Streptococcus pneumoniae in a 7-Month-Old Girl Who Received Three Doses of 13-Valent Pneumococcal Conjugate Vaccine
    Yoshida, Keishi
    Narazaki, Hidehiko
    Okada, Hajime
    Takagi, Atsushi
    Itoh, Yasuhiko
    JOURNAL OF NIPPON MEDICAL SCHOOL, 2020, 87 (05) : 299 - 303
  • [16] Meningitis caused by Streptococcus pneumoniae serotype 7a in an infant vaccinated with two doses of 13-valent pneumococcal conjugate vaccine: a case study
    Touhami, Kaoutar Ouazzani
    Sakkali, Hind El Bayed
    Maaloum, Fakhreddine
    Diawara, Idrissa
    Touhami, Makine Ouazzani
    Bezzari, Mohamed
    Zerouali, Khalid
    Belabbes, Houria
    PAN AFRICAN MEDICAL JOURNAL, 2019, 32
  • [17] A Narrative Review of the Molecular Epidemiology and Laboratory Surveillance of Vaccine Preventable Bacterial Meningitis Agents: Streptococcus pneumoniae, Neisseria meningitidis, Haemophilus influenzae and Streptococcus agalactiae
    Tsang, Raymond S. W.
    MICROORGANISMS, 2021, 9 (02) : 1 - 19
  • [18] Impact of 13-Valent Pneumococcal Conjugate Vaccine on Nasopharyngeal Carriage Rates of Streptococcus pneumoniae in a Rural Community in the Dominican Republic
    Dunn, Maria G.
    Lessa, Fernanda C.
    Sanchez, Jacqueline
    Cordero, Ramona
    Feris-Iglesias, Jesus
    Cedano, Doraliza
    Carvalho, Maria da Gloria
    Fernandez, Josefina
    Feemster, Kristen A.
    JOURNAL OF INFECTIOUS DISEASES, 2021, 224 : S237 - S247
  • [19] Pneumococcal carriage in vaccine-eligible children and unvaccinated infants in Lao PDR two years following the introduction of the 13-valent pneumococcal conjugate vaccine
    Satzke, Catherine
    Dunne, Eileen M.
    Choummanivong, Molina
    Ortika, Belinda D.
    Neal, Eleanor F. G.
    Pell, Casey L.
    Nation, Monica L.
    Fox, Kimberley K.
    Nguyen, Cattram D.
    Gould, Katherine A.
    Hinds, Jason
    Chanthongthip, Anisone
    Xeuatvongsa, Anonh
    Mulholland, E. Kim
    Sychareun, Vanphanom
    Russell, Fiona M.
    VACCINE, 2019, 37 (02) : 296 - 305
  • [20] Population genomics of pneumococcal carriage in South Africa following the introduction of the 13-valent pneumococcal conjugate vaccine (PCV13) immunization
    Javaid, Nida
    Olwagen, Courtney
    Nzenze, Susan
    Hawkins, Paulina
    Gladstone, Rebecca
    McGee, Lesley
    Breiman, Robert F.
    Bentley, Stephen D.
    Madhi, Shabir A.
    Lo, Stephanie
    MICROBIAL GENOMICS, 2022, 8 (06):